IP44-10: A Weighted Scale to Identify EMBARK-like Patients at High-Risk for Progression and Mortality after Biochemical Recurrence (BCR) Who May Benefit from Early Intensified ADT

IP44-10: A Weighted Scale to Identify EMBARK-like Patients at High-Risk for Progression and Mortality after Biochemical Recurrence (BCR) Who May Benefit from Early Intensified ADT

Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!